Is Simcere Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Simcere Pharmaceutical pays dividends. Last time was Monday 15th of July 2024 where the investors holding the stock on Tuesday 18th of June 2024 were paid HKD0.1757 per share. Over the last 4 times between 2021 and 2024, Simcere Pharmaceutical has paid HKD0.70747 with an average of HKD0.18 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Simcere Pharmaceutical 10 years ago, but if you had invested on Tuesday 27th of October 2020 when the price was HKD10.98, you would have made a loss of HKD-4.88 per share or -44.44%
Yes, the average daily trading liquidity for Simcere Pharmaceutical is HKD2.90 million. You should therefore be able to get in and out of your positions relatively fast.
Simcere Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.11, the company's ability to pay off the debt is normal. Simcere Pharmaceutical has a good net profit margin of 10.82% and should have high tolerances against inflation.
We have calculated the inflation risk for Simcere Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.